Food and Drug Administration, Division of Pharmaceutical Analysis, 1114 Market St., Saint Louis, MO 63101, USA.
J Chromatogr A. 2010 Nov 26;1217(48):7547-55. doi: 10.1016/j.chroma.2010.10.018. Epub 2010 Oct 11.
A high-pressure liquid chromatography-diode array detection and multi-mode ionization tandem mass spectrometry (HPLC-DAD-MMI-MS/MS) method was used to identify amino-tadalafil and rimonabant in electronic cigarette (e-cigarette) cartridges. Amino-tadalafil is a drug analogue of the commercially approved Cialis™ (i.e. tadalafil). Rimonabant is a drug that was, at one time, approved for weight loss in Europe (although approval has been retracted), but not in the United States. In addition, poor quality control over the e-cigarette products analyzed here is shown by the presence of nicotine in products labeled as containing no nicotine or by the presence of significant amounts of rimonabant oxidative degradant in e-cigarette products containing rimonabant. Identification was accomplished by comparing the retention time of relevant peaks in the sample with those of standard compounds, in addition to comparison of the UV spectra, mass spectra and/or product ion mass spectra.
采用高效液相色谱-二极管阵列检测-多模式离子串联质谱(HPLC-DAD-MMI-MS/MS)法鉴定电子烟(e-cigarette)烟弹中的氨基他达拉非和利莫那班。氨基他达拉非是一种已获商业批准的 Cialis™(即他达拉非)的药物类似物。利莫那班是一种药物,曾在欧洲获准用于减肥(尽管已被撤回批准),但未在美国获准。此外,此处分析的电子烟产品质量控制不佳,表现在标签为不含尼古丁的产品中含有尼古丁,或在含有利莫那班的电子烟产品中存在大量利莫那班氧化降解产物。通过将样品中相关峰的保留时间与标准化合物进行比较,以及比较紫外光谱、质谱和/或产物离子质谱,实现了鉴定。